title: Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
authors.forename: Manne
authors.initials: M
authors.lastname: Krop
authors.forename: Joep H M
authors.initials: JH
authors.lastname: van Esch
authors.forename: A H Jan
authors.initials: AH
authors.lastname: Danser
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D000808:Angiotensinogen / Q000378:metabolism; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002021:Buffers; D002216:Captopril / Q000494:pharmacology* / Q000627:therapeutic use; D048909:Diabetes Complications / Q000201:enzymology*; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology*; D004058:Diffusion; D016166:Free Radical Scavengers / Q000494:pharmacology* / Q000627:therapeutic use; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D007610:Kallikreins / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D017202:Myocardial Ischemia / Q000201:enzymology*; D009206:Myocardium / Q000378:metabolism*; D010477:Perfusion; D051381:Rats; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D038744:Ribosomal Protein S6 Kinases, 90-kDa / Q000502:physiology*; D013045:Species Specificity; D013777:Tetrazoles / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D002021:Buffers; D016166:Free Radical Scavengers; D007093:Imidazoles; D013777:Tetrazoles; D000808:Angiotensinogen; D000804:Angiotensin II; C437965:olmesartan; D002216:Captopril; D038744:Ribosomal Protein S6 Kinases, 90-kDa; D007610:Kallikreins; C489124:Klk26 protein, mouse